TG Therapeutics, which has operations in Morrisville, has secured a deal worth up to nearly $650 million to license its multiple sclerosis treatment outside of North America. Sales of the drop hit $16 million in the first full quarter of availability.
Read More
TG Therapeutics, which has an office in the Triangle for years, reportedly is moving company headquarters to North Carolina from New York.
Read More
Banner Life Sciences, a privately held specialty pharmaceutical company based in High Point, has gained final regulatory approval of a drug for treating multiple sclerosis.
Read More
The UNC School of Medicine lab of Jason Franz, PhD, created virtual reality experiments to show how a potentially portable and inexpensive test could reduce falls and related injuries in people with multiple sclerosis.
Read More
